Impact of Big Pharma Organizational Structure on R&D Productivity
Author : Sebastian Held
Publisher : BoD – Books on Demand
Page : 162 pages
File Size : 20,22 MB
Release : 2009
Category :
ISBN : 3936863164
Author : Sebastian Held
Publisher : BoD – Books on Demand
Page : 162 pages
File Size : 20,22 MB
Release : 2009
Category :
ISBN : 3936863164
Author : Burcu Kiliç
Publisher : Edward Elgar Publishing
Page : 285 pages
File Size : 45,39 MB
Release : 2014-07-31
Category : Law
ISBN : 1782544135
Boosting Pharmaceutical Innovation In The Post-TRIPS Era investigates the concept of innovation and illustrates the crucial role that patent strategies play within processes of pharmaceutical innovation. Drawing on extensive country and company case studies, it identifies the key issues relevant to the revival of local pharmaceutical industries.
Author : Luke O'Neill
Publisher : Swift Press
Page : 311 pages
File Size : 27,19 MB
Release : 2021-11-04
Category : Science
ISBN : 1800750773
A number one Irish bestseller, and winner of the Popular Non-Fiction Book of the Year at the Irish Book Awards In this fascinating and thought-provoking book, Professor Luke O'Neill grapples with life's biggest questions and tells us what science has to say about them. Covering topics from global pandemics to gender, addiction to euthanasia, Luke O'Neill's easy wit and clever pop-culture references deconstruct the science to make complex questions accessible. Arriving at science's definitive answers to some of the most controversial topics human beings have to grapple with, Never Mind the B#ll*ocks, Here's the Science is a celebration of science and hard facts in a time of fake news and sometimes unhelpful groupthink. 'A celebration of scientific fact in an era characterised by nebulous subjectivity' Irish Times
Author : Michael J. Kloep
Publisher : BoD – Books on Demand
Page : 214 pages
File Size : 41,63 MB
Release : 2012
Category : Hospitals
ISBN : 3936863202
Author : Institute of Medicine
Publisher : National Academies Press
Page : 225 pages
File Size : 40,32 MB
Release : 1991-02-01
Category : Medical
ISBN : 030904491X
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.
Author : Alexander Schuhmacher
Publisher : John Wiley & Sons
Page : 508 pages
File Size : 30,64 MB
Release : 2016-01-12
Category : Science
ISBN : 3527693416
This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.
Author : United States. Congress. House. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Publisher :
Page : 1040 pages
File Size : 48,25 MB
Release : 2014
Category : United States
ISBN :
Author : Robert M. Rydzewski
Publisher : Elsevier
Page : 535 pages
File Size : 13,1 MB
Release : 2010-07-07
Category : Medical
ISBN : 0080914888
Drug discovery increasingly requires a common understanding by researchers of the many and diverse factors that go into the making of new medicines. The scientist entering the field will immediately face important issues for which his education may not have prepared him: project teams, patent law, consultants, target product profiles, industry trends, Gantt charts, target validation, pharmacokinetics, proteomics, phenotype assays, biomarkers, and many other unfamiliar topics for which a basic understanding must somehow be obtained. Even the more experienced scientist can find it frustratingly difficult to get an overview of the many factors involved in modern drug discovery and often only after years of exploring does a whole and integrated picture emerge in the mind of the researcher.Real World Drug Discovery: A Chemist's Guide to Biotech and Pharmaceutical Research presents this kind of map of the landscape of drug discovery. In a single, readable volume it outlines processes and explains essential concepts and terms for the recent science graduate wondering what to expect in pharma or biotech, the medicinal chemist seeking a broader and more timely understanding of the industry, or the contractor or collaborator whose understanding of the commercial drug discovery process could increase the value of his contribution to it. - Interviews with well-known experts in many of the fields involved, giving insightful comments from authorities on many of the sub-disciplines important to cutting edge drug discovery. - Helpful suggestions gleaned from years of experience in biotech and pharma, which represents a repository drug discovery "lore" not previously available in any book. - "Periodic Table of Drugs" listing current top-selling drugs arranged by target and laid out so that structural similarities and differences are plain and clear. - Extensive use of diagrams to illustrate concepts like biotech startup models, preteomic profiling for target identification, Gantt charts for project planning, etc.
Author : Yves Morieux
Publisher : Harvard Business Review Press
Page : 232 pages
File Size : 12,25 MB
Release : 2014-03-11
Category : Business & Economics
ISBN : 1422190560
New tools for managing complexity Does your organization manage complexity by making things more complicated? If so, you are not alone. According to The Boston Consulting Group’s fascinating Complexity Index, business complexity has increased sixfold during the past sixty years. And, all the while, organizational complicatedness—that is, the number of structures, processes, committees, decision-making forums, and systems—has increased by a whopping factor of thirty-five. In their attempt to respond to the increasingly complex performance requirements they face, company leaders have created an organizational labyrinth that makes it more and more difficult to improve productivity and to pursue innovation. It also disengages and demotivates the workforce. Clearly it’s time for leaders to stop trying to manage complexity with their traditional tools and instead better leverage employees' intelligence. This book shows you how and explains the implications for designing and leading organizations. The way to manage complexity, the authors argue, is neither with the hard solutions of another era nor with the soft solutions—such as team building and feel-good “people initiatives”—that often follow in their wake. Based on social sciences (notably economics, game theory, and organizational sociology) and The Boston Consulting Group’s work with more than five hundred companies in more than forty countries and in various industries, authors Yves Morieux and Peter Tollman recommend six simple rules to manage complexity without getting complicated. Showing why the rules work and how to put them into practice, Morieux and Tollman give managers a much-needed tool to reinvigorate people in the face of seemingly endless complexity. Included are detailed examples from companies that have achieved a multiplicative effect on performance by using them. It’s time to manage complexity better. Employ these six simple rules to foster autonomy and cooperation and to effectively handle business complexity. As a result, you will improve productivity, innovate more, reengage your workforce, and seize opportunities to create competitive advantage.
Author : Giovanni Dosi
Publisher : OUP Oxford
Page : 404 pages
File Size : 30,8 MB
Release : 2001-11-29
Category : Business & Economics
ISBN : 0191530220
In this book, the editors and a team of distinguished international contributors analyse the nature of organizational capabilities–how organizations do things, use their knowledge base, and diffuse that knowledge in a competitive environment. Dosi is the author and editor of numerous books including Technology, Organization, and Competitiveness (OUP, 1998). He is also one of the editors of the journal Industrial and Corporate Change published by Oxford University Press. Nelson and Winter are recognized as leading proponents of evolutionary perspectives in economics and management. The book includes chapters from David Teece, Keith Pavitt, Benjamin Coriat, and Richard Florida amongst others.